Seegene Mexico
상단으로
Contáctenos

Noticias sobre productos Puedes verificar las últimas informaciones de productos

  • Obtained CE-IVD marking for Allplex™ STI Essential Assay Q(MH,UU)

    Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ STI Essential Assay Q(MH,UU). This assays?is a multiplex real-time PCR assay to simultaneously detect 7 pathogens causing sexually transmitted infections. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct value or quantitative result of each pathogen in a single channel. The quantitative result of Mycoplasma hominis and Ureaplasma urealyticum helps effective management of STIs.

    May 30, 2019 Allplex™ STI Essential Assay Q(MH,UU)

  • Obtained CE-IVD marking for Allplex™ Vaginitis Screening Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ Vaginitis Screening Assay. This assay is a Multiplex Real-time PCR assay that detects and identifies major pathogens related vaginitis simultaneously. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct values of each pathogen in a single channel. And it provides automated interpretation of BV using Seegene Viewer based on quantification information of major targets.

    Jan 25, 2019 Allplex™ Vaginitis Screening Assay

  • Obtained CE-IVD marking for Allplex™ MG & AziR Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ MG & AziR Assay. This assays?is a multiplex real-time PCR assay that detects and identifies?Mycoplasma genitalium?(MG) and 6 mutations causing azithromycin resistance. Azithromycin is generally prescribed for 1st-line treatment of MG. Based on Seegene’s proprietary DPO™ & MuDT™ Technology, this assay enables to check MG infection and azithromycin resistance in a single test and reports multiple Ct?values of each pathogen in a single tube.

    Oct 29, 2018 Allplex™ MG & AziR Assay

  • Obtained CE-IVD marking for Allplex™ Bacterial Vaginosis Assay

    Allplex™ Bacterial Vaginosis Assay simultaneously detects 7 bacteria (G. vaginalis, A. vaginae, Megasphaera type 1, BV-associated bacteria 2, Mobiluncus spp., B. fragilis, Lactobacillus spp.) associated with vaginosis. It provides quantitative information of 3 major bacteria (G. vaginalis, A. vaginae, Lactobacillus spp.).   Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report individual Ct  value of multiple bacteria in a single channel. The CE-IVD mark will allow more opportunities for Seegene to market and sell within the European Union.

    Dec 15, 2016 Allplex™ Bacterial Vaginosis Assay

  • Obtained CE-IVD marking for Allplex™ Genital ulcer Assay and Allplex™ Candidiasis Assay

    Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ Genital ulcer Assay and Allplex™ Candidiasis Assay. Allplex™ Genital ulcer Assay detects 7 pathogens (HSV1, HSV2, CMV, VZV, LGV related CMV, T. pallidum, H. ducreyi ) causing genital ulcer simultaneously. Allplex™ Candidiasis Assay detects and differentiate 7 candida spp.(C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. lusitaniae, C. dubliniensis )  causing candidiasis simultaneously. Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report multiple Ct values of each pathogen in a single channel using real-time PCR instruments.The CE mark will allow more opportunities for Seegene to market and sell within the European Union.

    Oct 14, 2016 Allplex™ Candidiasis Assay

  • Launched Allplex™ STI Essential Assay

    Allplex™ STI Essential Assay is a multiplex real-time PCR test that can simultaneously detect seven of the more common causes of STIs from a wide range of specimen types including genital swab, urine and liquid based cytology specimen. The Allplex™ STI Essential Assay will provide clinicians with a powerful tool to help protect health and prevent the spread of STIs.

    May 01, 2016 Allplex™ STI Essential Assay

  • Launched Anyplex™ II STI-7 Detection

    Anyplex™ II STI-7 Detection  Simultaneous detection of 7 STI causing pathogensAnyplex™ II STI-7 Detection detects 7 major STI causing pathogens in a single real-time PCR. Anyplex™ II STI-7 Detection enables the detection and differentiations of 7 major STI causative pathogens in a single real-time PCR reaction. The assay is based upon Seegene's proven DPO technology and its newly developed TOCE™ technology. A majority of Sexually Transmitted Infections (STI) can be asymptomatic and some have a high prevalence rate. If left untreated, they can become a major cause of diseases such as PID, extra uterine pregnancy, infertility, chronic pelvic pain, cervicitis and urethritis. Anyplex™ II STI-7 Detection is a test that not only prevents further spread of STIs but can also provide for effective STI treatments as it detects and differentiates the 7 major STI causative pathogens. Anyplex™ II STI-7 Detection is provided with on Internal control (STI-7 IC). This STI-7 IC enables the user can confirm the nucleic acid isolation and to check a possibility containig inhibitor.

    Aug 31, 2012 Anyplex™Ⅱ STI-7 Detection

  • Launched Anyplex™ TV/MH Real-time Detection

    Detection of T. vaginalis and M. hominisAnyplex™ TV/MH Real-time Detection enables simultaneous detection of Trichomonas vaginalis (TV) and Mycoplasma hominis (MH) by multiplex Real-time PCR.   Anyplex™ TV/MH Real-time Detection enables simultaneous detection of Trichomonas vaginalis (TV) and Mycoplasma hominis (MH) by multiplex Real-time PCR using urine specimen, swab specimen (urethral, vaginal and cervical) and liquid based cytology specimen. T. vaginalis and M. hominis are the pathogens associated with sexually transmitted infections such as urethritis, cervicitis, vaginitis, pelvic inflammatory disease (PID) and infertility. Fast and accurate diagnosis is important for treatments since most infections are asymptomatic. The conventional methods (ELISA, Giemsa stain, culture, etc.) for STD pathogen detection take several days or are poor in sensitivity. Anyplex™ TV/MH Real-time Detection is an accurate and rapid diagnostic method for the detection of T. vaginalis and M. hominis. Anyplex™ TV/MH Real-time Detection is provided with an Internal Control (TV/MH IC). This TV/MH IC enables the user to control and confirm the nucleic acid isolation procedure as well as checking possibility of PCR inhibition.  

    Oct 01, 2011 Anyplex™ TV/MH Real-time Detection